Analysis

Breaking News

TeraPore launches IsoBlock VF viral filtration products with proprietary membrane technology

TeraPore Technologies, an innovator in nanofiltration membranes, has commercially launched the flagship IsoBlock VF product line for parvovirus rem...

MIMETAS and Yamaha Motor Sign Joint Marketing Agreement Aimed at Advancing Therapeutic Development

Both companies will collaborate to develop innovative applications of the CELL HANDLER in combination with MIMETAS’ 3D tissue models

CatSci expands capabilities to offer expert cGMP analytical development services

CatSci is thrilled to announce the launch of its expert cGMP analytical capabilities in Dagenham, UK

Diagnosing hormone-based disorders using saliva

Diagnosing hormone-based disorders using saliva samples dates back to the 1980s; however, it’s only the sensitivity improvements that have occurred...

Xybion acquires Autoscribe Informatics to expand its LIMS business

Xybion Corporation is pleased to announce the acquisition of Autoscribe Informatics. This represents a significant strategic expansion in the compa...

Resolian acquires China-based bioanalytical CRO Denali Medpharma

Resolian, a global bioanalytical contract research organisation (CRO) specialising in drug metabolism and pharmacokinetics for small and large mole...

Analytical method development in a high potent facility

Analytical method development is a cornerstone of pharmaceutical outsourcing. In this Q&A with Dr Kevin Robinson (KSR), Amanda Blackwell (AB), Head...

From food to pharma: antioxidant scavengers as a viable strategy to mitigate nitrosamines in drugs

Stakeholders throughout the pharmaceutical value chain have had to deal with the recall of nitrosamine-containing medications, loss of revenue and,...

ATCC and USP launch product range to reduce risk in vaccine development

ATCC and USP have launched the first set of products from their collaboration to advance quality and reduce risk in the development of biological t...

Navigating CMC challenges in NBE and therapeutic antibody development

Insights by Dr Thomas Flad, Senior Director of Solutions & Innovation at ProtaGene, as he poses solutions to the difficulty matching analytical res...

How self-replicating RNA can transform in vitro-transcribed drug development

In vitro-transcribed (IVT) ribonucleic acids (RNAs) are integral to next-generation nucleic acid-based drugs. The recent success of messenger RNA (...

Host cell protein analysis: strategies to improve sensitivity and reproducibility

Given that the US FDA approved 25 new cellular and gene therapy products in 2022, gene-based vaccines and therapeutics have now entered the mainstr...

Genomic Vision launches cell characterisation service for biomanufacturing

The France-based company has launched HexaCard, a new service for characterising transformed cell lines

Overcoming cell separation challenges to advance stem cell therapy research

Stem cell therapies are cutting-edge techniques that show promise as highly effective treatments for a wide range of health conditions, including b...